eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 30/03/2011
PIL Pneumovax II

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/05/2010 and displayed until 30/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/06/2009 and displayed until 14/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 12/08/2008 and displayed until 22/06/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change of trade or generic name
  • Change to date of revision
Updated on 05/12/2007 and displayed until 12/08/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 21/09/2007 and displayed until 05/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 01/06/2007 and displayed until 21/09/2007
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 21/08/2006 and displayed until 01/06/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to packaging
  • Change to date of revision
Updated on 07/07/2006 and displayed until 21/08/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/04/2006 and displayed until 07/07/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   pneumococcal polysaccharide vaccine ph. eur